Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms-Reference-Cited by-同舟云学术

Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms

Published:2018-01-17 Issue:4 Volume:94 Page:576-587
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Starostka David¹,Kriegova Eva²,Kudelka Milos³,Mikula Peter¹,Zehnalova Sarka³,Radvansky Martin³,Papajik Tomas⁴,Kolacek David¹,Chasakova Katerina¹,Talianova Hana¹

Affiliation:

1. Department of Clinical Haematology; Hospital in Havirov; Czech Republic

2. Department of Immunology; Palacky University & University Hospital Olomouc; Czech Republic

3. Department of Computer Science, Faculty of Electrical Engineering and Computer Science; Technical University of Ostrava; Czech Republic

4. Department of Haemato-oncology; Palacky University & University Hospital Olomouc; Czech Republic

Funder

Ministry of Health of the Czech Republic

Ministry of Health, Czech Republic

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cyto.b.21607/fullpdf

Reference53 articles.

1. Quantitative flow cytometry: Concerns and recommendations in clinic and research;Mizrahi;Cytometry B Clin Cytom,2017

2. Serum protein fingerprinting by PEA immunoassay coupled with a pattern-recognition algorithms distinguishes MGUS and multiple myeloma;Schneiderova;Oncotarget,2017

3. Zehnalova S Kudelka M Platos J Horak Z. 2014 870 875

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases;Diagnostic Pathology;2024-04-16

2. Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders;Critical Reviews in Clinical Laboratory Sciences;2022-09-06

3. CD200 as a Valuable Marker for Differentiating between CLL and Other B-cell Lymph Proliferative Disorders;INTERNATIONAL JOURNAL OF HUMAN GENETICS;2022-04-25

4. Exploring a peptide nucleic acid-based antisense approach for CD5 targeting in chronic lymphocytic leukemia;PLOS ONE;2022-03-31

5. Contemporary Challenges in Clinical Flow Cytometry: Small Samples, Big Data, Little Time;The Journal of Applied Laboratory Medicine;2022-01-21